Can a new pill slow Parkinson's symptoms?
Disease control
Not yet recruiting
This clinical trial is testing an experimental medication called TJ0113 in people with early-onset Parkinson's disease. The study aims to see if TJ0113 can improve movement symptoms compared to a placebo. About 300 participants will take either TJ0113 or a placebo for 26 weeks, f…
Phase: PHASE3 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC